Diaphragmatic CMAP Monitoring During Cryoballoon Procedures: Surface vs. Hepatic Recording Comparison and Limitations of This Approach.

atrial fibrillation compound motor action potential cryoballoon ablation phrenic nerve palsy pulmonary vein isolation

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 12 11 2021
accepted: 17 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Compound motor action potential (CMAP) monitoring is a common method used to prevent right phrenic nerve palsy during cryoballoon ablation for atrial fibrillation. We compared recordings simultaneously obtained with surface and hepatic electrodes. We included 114 consecutive patients (mean age 61.7 ± 10.9 years) admitted to our department for cryoballoon ablation. CMAP was monitored simultaneously with a hepatic catheter and a modified lead I ECG, whilst right phrenic nerve was paced before (stage 1) and during (stage 2) the right-sided freezes. If phrenic threat was detected with hepatic recordings (CMAP amplitude drop >30%) the application was discontinued with forced deflation. The ratio of CMAP/QRS was 4.63 (2.67-9.46) for hepatic and 0.76 (0.55-1.14) for surface ( Both methods are feasible with the same signal stability and amplitude drop precocity during phrenic threats. Clarity and legibility are significantly better with hepatic recording (sharper signals, less far-field QRS). The two main limitations were pacing instability and delay between 30% CMAP decrease and cryoapplication discontinuation.

Sections du résumé

BACKGROUND BACKGROUND
Compound motor action potential (CMAP) monitoring is a common method used to prevent right phrenic nerve palsy during cryoballoon ablation for atrial fibrillation.
OBJECTIVE OBJECTIVE
We compared recordings simultaneously obtained with surface and hepatic electrodes.
METHODS METHODS
We included 114 consecutive patients (mean age 61.7 ± 10.9 years) admitted to our department for cryoballoon ablation. CMAP was monitored simultaneously with a hepatic catheter and a modified lead I ECG, whilst right phrenic nerve was paced before (stage 1) and during (stage 2) the right-sided freezes. If phrenic threat was detected with hepatic recordings (CMAP amplitude drop >30%) the application was discontinued with forced deflation.
RESULTS RESULTS
The ratio of CMAP/QRS was 4.63 (2.67-9.46) for hepatic and 0.76 (0.55-1.14) for surface (
CONCLUSION CONCLUSIONS
Both methods are feasible with the same signal stability and amplitude drop precocity during phrenic threats. Clarity and legibility are significantly better with hepatic recording (sharper signals, less far-field QRS). The two main limitations were pacing instability and delay between 30% CMAP decrease and cryoapplication discontinuation.

Identifiants

pubmed: 35211527
doi: 10.3389/fcvm.2022.814026
pmc: PMC8861293
doi:

Types de publication

Journal Article

Langues

eng

Pagination

814026

Informations de copyright

Copyright © 2022 Tovmassian, Maille, Koutbi, Hourdain, Martinez, Zabern, Deharo and Franceschi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Circ Arrhythm Electrophysiol. 2012 Feb;5(1):220-8
pubmed: 22334429
J Cardiovasc Electrophysiol. 2005 Mar;16(3):309-13
pubmed: 15817092
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Int J Med Sci. 2016 May 10;13(6):403-11
pubmed: 27279788
Am J Cardiol. 2020 Apr 15;125(8):1170-1179
pubmed: 32087997
N Engl J Med. 2016 Jun 9;374(23):2235-45
pubmed: 27042964
Circ Arrhythm Electrophysiol. 2015 Apr;8(2):303-7
pubmed: 25740826
Heart Rhythm. 2014 Oct;11(10):1839-44
pubmed: 24952147
J Cardiovasc Electrophysiol. 2014 Jan;25(1):1-7
pubmed: 24134539
Heart Rhythm. 2011 Jun;8(6):885-91
pubmed: 21256978
Circulation. 2015 Oct 6;132(14):1311-9
pubmed: 26283655
Muscle Nerve. 2009 Jul;40(1):37-41
pubmed: 19533636
Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1109-14
pubmed: 24114777
Heart Rhythm. 2011 Jul;8(7):1068-71
pubmed: 21315843
Europace. 2017 Mar 1;19(3):378-384
pubmed: 27702864

Auteurs

Lilith Tovmassian (L)

Department of Cardiology, CHU Timone, Marseille, France.
Aix-Marseille Université, Faculté de Médecine,Marseille, France.

Baptiste Maille (B)

Department of Cardiology, CHU Timone, Marseille, France.
Aix-Marseille Université, Faculté de Médecine,Marseille, France.
Center for CardioVascular and Nutrition Research (C2VN), INSERM, INRA, Marseille, France.
Aix-Marseille University, Marseille, France.

Linda Koutbi (L)

Department of Cardiology, CHU Timone, Marseille, France.
Aix-Marseille Université, Faculté de Médecine,Marseille, France.

Jérôme Hourdain (J)

Department of Cardiology, CHU Timone, Marseille, France.
Aix-Marseille Université, Faculté de Médecine,Marseille, France.

Elisa Martinez (E)

Department of Cardiology, CHU Timone, Marseille, France.
Aix-Marseille Université, Faculté de Médecine,Marseille, France.

Maxime Zabern (M)

Department of Cardiology, CHU Timone, Marseille, France.
Aix-Marseille Université, Faculté de Médecine,Marseille, France.

Jean-Claude Deharo (JC)

Department of Cardiology, CHU Timone, Marseille, France.
Aix-Marseille Université, Faculté de Médecine,Marseille, France.
Center for CardioVascular and Nutrition Research (C2VN), INSERM, INRA, Marseille, France.
Aix-Marseille University, Marseille, France.

Frédéric Franceschi (F)

Department of Cardiology, CHU Timone, Marseille, France.
Aix-Marseille Université, Faculté de Médecine,Marseille, France.
Center for CardioVascular and Nutrition Research (C2VN), INSERM, INRA, Marseille, France.
Aix-Marseille University, Marseille, France.

Classifications MeSH